Search

Displaying results 9361 - 9370 of 10000 in total
  1. Drug

    Tamuzimod

    go.drugbank.com/drugs/DB21621
    Investigational

    The usage of the INN stem '-imod' in the name indicates that Tamuzimod is a immunomodulator, both stimulant/suppressive and stimulant. … Tamuzimod is under investigation in clinical trial NCT05156125 (VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis).

  2. Drug

    ATX-201

    go.drugbank.com/drugs/DB05765
    Investigational

    ATX-201 is one of a family of novel compounds that inhibits microtubule polymerization. It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX...

  3. Drug

    PPL-100

    go.drugbank.com/drugs/DB05961
    Investigational

  4. Drug

    BIIB015

    go.drugbank.com/drugs/DB06304
    Investigational

    BIIB015 is a humanized, IgG1 [immunoglobulin G 1], DM4-Conjugated, anti-cripto, monoclonal antibody. It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.

  5. Drug

    Evernimicin

    go.drugbank.com/drugs/DB06431
    Experimental

  6. Drug

    Tecastemizole

    go.drugbank.com/drugs/DB06457
    Experimental

  7. Drug

    Liatermin

    go.drugbank.com/drugs/DB06489
    Investigational

  8. Drug

    Siramesine

    go.drugbank.com/drugs/DB06555
    Experimental

  9. Drug

    Baminercept

    go.drugbank.com/drugs/DB06576
    Investigational

  10. Drug

    7-beta-Hydroxyepiandrosterone

    go.drugbank.com/drugs/DB06622
    Investigational